DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-204

Akki the basher who has no clue about biotechs ,, if current DMD trial is successful then another larger one with minimum 80-100 patients is required for market approval , the clinical trial will cost between $25-30 million who gonna paid that ????? ANP has not the power nor the money to bring it alone through the larger trial and to market . So if the ongoing trial is successful then ANP has no other choice than to out-license the drug . Again positive phase 2 results will push the stock massive to the upside and will attract potential partners or company getting bought .

ATL1102 is available for licensing
https://adisinsight.springer.com/drugs/800013427